Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C Anderson

Showing results (121-130 of 868) with videos related to

Pageof 87
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Best treatment strategies in high-risk multiple myeloma: navigating a gray areaGiada Bianchi, Paul G Richardson, Kenneth C Anderson
Immunotargets and Therapy|October 29, 2020
Immunotherapeutic and Targeted Approaches in Multiple MyelomaOmar Nadeem, Yu-Tzu Tai, Kenneth C Anderson
Expert Opinion on Investigational Drugs|January 26, 2006
Current therapeutic uses of lenalidomide in multiple myelomaTeru Hideshima, Paul G Richardson, Kenneth C Anderson
Molecular Cancer Therapeutics|November 11, 2011
Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myelomaTeru Hideshima, Paul G Richardson, Kenneth C Anderson
Cancer Control : Journal of the Moffitt Cancer Center|October 29, 2003
Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancersPaul G Richardson, Teru Hideshima, Kenneth C Anderson
Reviews in Clinical and Experimental Hematology|February 7, 2004
Targeting proteasome inhibition in hematologic malignanciesTeru Hideshima, Paul G Richardson, Kenneth C Anderson
Hematology/Oncology Clinics of North America|September 13, 2014
Immunotherapy strategies in multiple myelomaJooeun Bae, Nikhil C Munshi, Kenneth C Anderson
Thescientificworldjournal|December 13, 2006
New frontiers in the treatment of multiple myelomaJanice Jin Hwang, Irene M Ghobrial, Kenneth C Anderson
Cancer Research|July 25, 2006
Proteasome inhibitor drugs on the riseClaudio A P Joazeiro, Kenneth C Anderson, Tony Hunter
Best Practice & Research. Clinical Haematology|July 20, 2005
Cytokines and signal transductionTeru Hideshima, Klaus Podar, Dharminder Chauhan, et al.
Pageof 87

Showing results (121-130 of 868) with videos related to

Sort By:
Pageof 87
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Best treatment strategies in high-risk multiple myeloma: navigating a gray areaGiada Bianchi, Paul G Richardson, Kenneth C Anderson
Immunotargets and Therapy|October 29, 2020
Immunotherapeutic and Targeted Approaches in Multiple MyelomaOmar Nadeem, Yu-Tzu Tai, Kenneth C Anderson
Expert Opinion on Investigational Drugs|January 26, 2006
Current therapeutic uses of lenalidomide in multiple myelomaTeru Hideshima, Paul G Richardson, Kenneth C Anderson
Molecular Cancer Therapeutics|November 11, 2011
Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myelomaTeru Hideshima, Paul G Richardson, Kenneth C Anderson
Cancer Control : Journal of the Moffitt Cancer Center|October 29, 2003
Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancersPaul G Richardson, Teru Hideshima, Kenneth C Anderson
Reviews in Clinical and Experimental Hematology|February 7, 2004
Targeting proteasome inhibition in hematologic malignanciesTeru Hideshima, Paul G Richardson, Kenneth C Anderson
Hematology/Oncology Clinics of North America|September 13, 2014
Immunotherapy strategies in multiple myelomaJooeun Bae, Nikhil C Munshi, Kenneth C Anderson
Thescientificworldjournal|December 13, 2006
New frontiers in the treatment of multiple myelomaJanice Jin Hwang, Irene M Ghobrial, Kenneth C Anderson
Cancer Research|July 25, 2006
Proteasome inhibitor drugs on the riseClaudio A P Joazeiro, Kenneth C Anderson, Tony Hunter
Best Practice & Research. Clinical Haematology|July 20, 2005
Cytokines and signal transductionTeru Hideshima, Klaus Podar, Dharminder Chauhan, et al.
Pageof 87